Acute gastrointestinal distress syndrome in patients with systemic lupus erythematosus

Lupus

Volumn 16, Issue 2, 2007, Pages 137-141

  Kishimoto, M ^a   Nasir, A ^a   Mor, A ^a   Belmont, H Michael ^a  

^a NYU HOSPITAL FOR JOINT DISEASES   (United States)

Author keywords

Mesenteric vasculitis; Systemic lupus erythematosus

Indexed keywords

ANTIBIOTIC AGENT; AZATHIOPRINE; CEPHALOSPORIN; CYCLOPHOSPHAMIDE; DAPSONE; HISTAMINE H2 RECEPTOR ANTAGONIST; HYDROXYCHLOROQUINE; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; STEROID; THALIDOMIDE;

ACUTE GASTROINTESTINAL DISTRESS SYNDROME; ADULT; ANAMNESIS; ARTICLE; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG MEGADOSE; DRUG WITHDRAWAL; ENTEROCOLITIS; FEMALE; GASTROINTESTINAL SYMPTOM; HUMAN; HYPOCOMPLEMENTEMIA; LAPAROSCOPY; MYOSITIS; PRIORITY JOURNAL; RASH; RAYNAUD PHENOMENON; SKIN ULCER; SYSTEMIC LUPUS ERYTHEMATOSUS; VASCULAR DISEASE; VASCULITIS;

ACUTE DISEASE; ADULT; FEMALE; GASTROINTESTINAL DISEASES; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MESENTERIC ARTERIES; MESENTERIC VEINS; SYNDROME; VASCULITIS;

EID: 33847347990     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1177/0961203306075739     Document Type: Article

References (18)

1. Boumpas DT, Austin HA, Fessier BJ, Balow JE, Klippel JH, Lockshin MD. Systemic lupus erythematosus: emerging concepts. Part 1. Renal, neuropsychiatric, cardiovascular and heamtologic disease. Ann Intern Med 1995; 122: 940-950.
2. Boumpas DT, Fessler BJ, Austin HA, Balow JE, Klippel JH, Lockshin MD. Systemic lupus erythematosus: emerging concepts. Part 2: Dermatologic and joint disease, the antiphospholipid antibody syndrome, pregnancy and hormonal therapy, morbidity and mortality, and pathogenesis. Ann Intern Med 1995; 123: 42-53.
3. Belmont HM, Abramson SB, Lie JT. Pathology and pathogenesis of vascular injury in systemic lupus erythematosus. Interactions of inflammatory cells and activated endothelium. Arthritis Rheum 1996; 39: 9-22.
4. Golden B, Belmont HM. The role of microvasculopathy in the catastrophic antiphospholipid syndrome:comment on the article by Neuwelt et al. Arthritis Rheum 1998; 41: 751-752.
5. Sultan SM, Ioannou Y, Isenberg DA. A review of gastrointestinal manifestations of systemic lupus erythematosus. Rheumatology 1999; 38: 917-932.
6. Vitali C, Bencivelli W, Isenberg DA. et al. Disease activity in systemic lupus erythematosus: report of the Consensus Study Group of the European Workshop for Rheumatology Research. I. A descriptive analysis of 704 European lupus patients. European Consensus Study Group for Disease Activity in SLE. Clin Exp Rheumatol 1992; 10: 527-539.
7. Zizic TM, Classen JN, Stevens MB. Acute abdominal complications of systemic lupus erythematosus and polyarteritis nodosa. Am J Med 1982; 73: 525-531.
8. Kaneko Y, Hirakata M, Suwa A et al. Systemic lupus erythematosus associated with recurrent lupus enteritis and peritonitis. Clin Rhematology 2004; 23: 351-354.
9. Lian TY, Edwards CJ, Chan SP, Chng HH et al. Reversible acute gastrointestinal syndrome associated with active systemic lupus eryuthematosus in patients admitted to hospital. Lupus 2003; 12: 612-616.
10. Kaushik S, Federle MP, Schur PH, Krishnan M, Silverman SG, Ros PR. Abnormal thrombotic and ischemic manifestations of the antiphospholipid antibody syndrome: CT findings in 42 patients. Radiology 2001; 218: 768-771.
11. Sanchez-Guerrero J, Reyes E, Alarcon Segovia D. Primary antiphospholipid syndromes as a cause of intestinal infarction. J Rheumatol 1992; 19: 623-625.
12. Hopkins P, Belmont HM, Buyon J, Philips M, Weissmann G, Abramson SB. Increased levels of plasma anaphylatoxins in systemic lupus erythematosus predict flares of the disease and may elicit vascular injury in lupus cerebritis. Arthritis Rheum 1988; 31: 632-641.
13. Abramson SB, Dobro J, Eberle MA et al. Acute reversible hypoxemia in systemic lupus erythematosus. Ann Intern Med 1991; 114: 941-947.
14. Bone RC. Why new definitions of sepsis and organ failure are needed. Am J Med 1993; 95: 348-350.
15. Waage A, Brandtzaeg P, Espevik T, Halstensen A. Current understanding of the pathogenesis of gram-negative shock. Infect Dis Clin North Am 1991; 5: 781-791.
16. Niederbichler AD, Hoesel LM, Westfall MV et al. An essential role for complement C5a in the pathogenesis of septic cardiac dysfunction J Exp Med 2006; 203: 53-61.
17. Guo RF, Riedemann NC, Ward PA. Role of C5a-C5aR interaction in sepsis. Shock 2004; 21: 1-7.
18. Schuerholz T, Leuwer M, Cobas-Meyer M et al. Terminal complement complex in septic shock with capillary leakage: marker of complement activation? Eur J Anaesthesiol 2005; 22: 541-547.